RS

Radhe Shyam Tiwari

Active Director Director DIN 10136734
DIN 10136734 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Radhe Shyam Tiwari

Data last updated:

Radhe Shyam Tiwari is a Director at Vrindar Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10136734
Primary Designation Director
Industry Pharma
First Appointment 27 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Apr 20232023Active

Board colleagues of Radhe Shyam Tiwari

NameDINCompanyDesignation
Reena Tiwari10136733Vrindar Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vrindar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Radhe Shyam Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radhe Shyam Tiwari

Radhe Shyam Tiwari currently holds 1 directorship: Vrindar Pharmaceuticals Private Limited (Director, since 27 Apr 2023).

Radhe Shyam Tiwari was first appointed on 27 Apr 2023 as Director at Vrindar Pharmaceuticals Private Limited.

The current boards of Radhe Shyam Tiwari's companies include Reena Tiwari (Vrindar Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available